Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dendritic Cells | 7 | 2023 | 2746 | 1.040 |
Why?
|
Properdin | 3 | 2017 | 29 | 0.830 |
Why?
|
Interleukin-18 | 2 | 2021 | 251 | 0.800 |
Why?
|
Complement Pathway, Alternative | 2 | 2017 | 116 | 0.660 |
Why?
|
Panniculitis | 1 | 2018 | 45 | 0.620 |
Why?
|
Complement Factor H | 1 | 2017 | 110 | 0.550 |
Why?
|
Lymphoma, T-Cell | 1 | 2018 | 304 | 0.530 |
Why?
|
Inflammasomes | 1 | 2021 | 525 | 0.520 |
Why?
|
Interleukin-12 | 2 | 2015 | 583 | 0.490 |
Why?
|
Interleukins | 2 | 2015 | 782 | 0.440 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 1412 | 0.390 |
Why?
|
Autoimmunity | 2 | 2022 | 1355 | 0.370 |
Why?
|
Immune Tolerance | 2 | 2017 | 2300 | 0.340 |
Why?
|
Neoplasms | 4 | 2024 | 22164 | 0.330 |
Why?
|
Phagocytosis | 1 | 2014 | 1536 | 0.300 |
Why?
|
Cell Communication | 1 | 2014 | 1657 | 0.280 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 2 | 2024 | 174 | 0.260 |
Why?
|
Immunotherapy | 2 | 2023 | 4650 | 0.260 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4370 | 0.230 |
Why?
|
Fibroblasts | 1 | 2014 | 4140 | 0.220 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2024 | 152 | 0.220 |
Why?
|
Kidney | 2 | 2016 | 7049 | 0.200 |
Why?
|
Toll-Like Receptor 9 | 1 | 2023 | 233 | 0.190 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9179 | 0.180 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2024 | 4575 | 0.180 |
Why?
|
Myeloid Cells | 1 | 2024 | 823 | 0.160 |
Why?
|
Th17 Cells | 1 | 2024 | 794 | 0.150 |
Why?
|
Apoptosis | 1 | 2014 | 9488 | 0.150 |
Why?
|
Gene Expression Regulation | 2 | 2024 | 11902 | 0.150 |
Why?
|
Molecular Chaperones | 1 | 2022 | 755 | 0.140 |
Why?
|
Complement C3b | 1 | 2017 | 99 | 0.140 |
Why?
|
Melanoma, Experimental | 1 | 2020 | 560 | 0.140 |
Why?
|
Complement C3 | 2 | 2016 | 451 | 0.140 |
Why?
|
Antigen Presentation | 1 | 2022 | 1253 | 0.140 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2022 | 822 | 0.130 |
Why?
|
Complement C5 | 1 | 2016 | 106 | 0.130 |
Why?
|
Interleukin-12 Subunit p35 | 1 | 2015 | 21 | 0.130 |
Why?
|
Interleukin-1beta | 1 | 2021 | 997 | 0.120 |
Why?
|
Germ Cells | 1 | 2018 | 634 | 0.120 |
Why?
|
Isoantigens | 1 | 2017 | 552 | 0.120 |
Why?
|
Mice, Knockout | 3 | 2024 | 14409 | 0.120 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2015 | 293 | 0.120 |
Why?
|
Complement Activation | 1 | 2016 | 452 | 0.110 |
Why?
|
Homeostasis | 1 | 2024 | 3321 | 0.110 |
Why?
|
Antigen-Presenting Cells | 1 | 2015 | 965 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2020 | 2161 | 0.090 |
Why?
|
Mice | 7 | 2024 | 81509 | 0.090 |
Why?
|
Peroxidase | 1 | 2013 | 609 | 0.090 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2013 | 225 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2018 | 1858 | 0.090 |
Why?
|
Coculture Techniques | 1 | 2014 | 1340 | 0.090 |
Why?
|
Immunomodulation | 1 | 2014 | 548 | 0.090 |
Why?
|
Lymphocyte Activation | 2 | 2020 | 5490 | 0.090 |
Why?
|
Cells, Cultured | 2 | 2017 | 18964 | 0.090 |
Why?
|
Necrosis | 1 | 2014 | 1608 | 0.080 |
Why?
|
Hematopoietic Stem Cells | 1 | 2022 | 3396 | 0.080 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22163 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2017 | 3159 | 0.080 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 3428 | 0.070 |
Why?
|
Dexamethasone | 1 | 2015 | 1947 | 0.070 |
Why?
|
Lipopolysaccharides | 1 | 2015 | 2207 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3874 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5794 | 0.070 |
Why?
|
T-Lymphocytes | 2 | 2022 | 10194 | 0.070 |
Why?
|
Animals | 7 | 2024 | 168441 | 0.060 |
Why?
|
Macrophages | 1 | 2020 | 5768 | 0.060 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3823 | 0.060 |
Why?
|
Graft vs Leukemia Effect | 1 | 2024 | 121 | 0.060 |
Why?
|
Cell Line | 2 | 2016 | 15605 | 0.060 |
Why?
|
Interleukin-23 | 1 | 2024 | 201 | 0.050 |
Why?
|
Protein Binding | 3 | 2024 | 9352 | 0.050 |
Why?
|
Gene Expression | 1 | 2015 | 7584 | 0.050 |
Why?
|
Humans | 10 | 2024 | 761423 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2017 | 10441 | 0.050 |
Why?
|
Neutrophils | 1 | 2013 | 3766 | 0.050 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2024 | 651 | 0.050 |
Why?
|
Oligonucleotides, Antisense | 1 | 2023 | 461 | 0.040 |
Why?
|
Receptors, Glucocorticoid | 1 | 2020 | 305 | 0.040 |
Why?
|
Oncogenes | 1 | 2024 | 1222 | 0.040 |
Why?
|
Ligands | 1 | 2024 | 3271 | 0.040 |
Why?
|
Phenotype | 1 | 2015 | 16606 | 0.040 |
Why?
|
Cell Differentiation | 2 | 2024 | 11526 | 0.030 |
Why?
|
Cathepsin G | 1 | 2013 | 31 | 0.030 |
Why?
|
Complement Membrane Attack Complex | 1 | 2013 | 105 | 0.030 |
Why?
|
Pancreatic Elastase | 1 | 2013 | 127 | 0.030 |
Why?
|
Muramidase | 1 | 2013 | 169 | 0.030 |
Why?
|
Myeloblastin | 1 | 2013 | 101 | 0.030 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2013 | 353 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2022 | 2898 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2020 | 2049 | 0.020 |
Why?
|
Signal Transduction | 2 | 2024 | 23441 | 0.020 |
Why?
|
Blood Proteins | 1 | 2013 | 1180 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2024 | 3613 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3077 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2024 | 5670 | 0.020 |
Why?
|
Inflammation | 1 | 2024 | 10762 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2016 | 3667 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16979 | 0.010 |
Why?
|
Male | 1 | 2021 | 360736 | 0.010 |
Why?
|
Female | 1 | 2021 | 392581 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2013 | 3061 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2013 | 4936 | 0.010 |
Why?
|
Concepts
(103)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_